Description
Research Peptide≥99% HPLC StandardShips from Canada
Overview
Cartalax is a short synthetic peptide bioregulator studied in the tradition of low-molecular-weight regulatory peptides. It is supplied as a stable lyophilized peptide.
Short peptides of this type are examined in research for interactions with connective-tissue and cartilage cells and for possible influence on gene-expression patterns; the specific published literature on Cartalax itself is very limited. It is offered strictly as a research material for laboratory investigation only.
Mechanisms of interest in research
Short-peptide bioregulator activity
Cartalax belongs to a class of short synthetic peptides investigated for tissue-selective regulatory effects, proposed to interact with cells of connective tissue and cartilage. Because direct published studies of Cartalax are scarce, its mechanism is not well characterised and is described here only in general terms.
Specifications
This product is intended exclusively for in-vitro laboratory research. It is not a drug, food, dietary supplement, or cosmetic, and it is not intended for human or veterinary diagnostic, therapeutic, or recreational use.
